Finance

Beta
Lists
MAAT:EPA
Maat Pharma SA
€2.85
+7.75%
(+0.20) 1D
May 29, 5:35:19 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for MAAT...
Open
€2.70
High
€2.89
Low
€2.68
Mkt. cap
53.48M
Avg. vol.
144.16K
Volume
147.33K
52-wk high
€8.62
52-wk low
€2.60
EPS
-€1.95
Shares outstanding
18.82M
No. of employees
56
Open
€2.70
High
€2.89
Low
€2.68
Mkt. cap
53.48M
Avg. vol.
144.16K
Volume
147.33K
52-wk high
€8.62
52-wk low
€2.60
EPS
-€1.95
Shares outstanding
18.82M
No. of employees
56
News stories
From sources across the web
About Maat Pharma SA
CEO-
Employees56
Founded2014
Headquarters-
SectorBiotechnology
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
1.21M
1.21M
1.05M
1.05M
Cost of goods sold
395.00K
395.00K
469.00K
469.00K
Cost of revenue
395.00K
395.00K
469.00K
469.00K
Research and development expenses
7.39M
7.39M
6.94M
6.94M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.05M
2.05M
2.04M
2.04M
Operating expense
8.19M
8.19M
8.07M
8.07M
Total operating expenses
8.59M
8.59M
8.54M
8.54M
Operating income
-7.37M
-7.37M
-7.49M
-7.49M
Other non operating income
-4.00K
-4.00K
-31.50K
-31.50K
EBT including unusual items
-7.54M
-7.54M
-7.99M
-7.99M
EBT excluding unusual items
-7.54M
-7.54M
-7.99M
-7.99M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-1.25M
-1.25M
-915.00K
-915.00K
Net income
-7.54M
-7.54M
-7.99M
-7.99M
Net profit margin
-621.55%
-621.55%
-761.85%
-761.85%
Earnings per share
-
-
-
-
Interest and investment income
43.50K
43.50K
-
-
Interest expense
-207.50K
-207.50K
-466.50K
-466.50K
Net interest expenses
-164.00K
-164.00K
-466.50K
-466.50K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.33M
-7.33M
-7.38M
-7.38M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more